Carolina Firacative
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Novel cyp51A mutation profile in Aspergillus fumigatus from a patient with systemic lupus erythematosus and limited systemic sclerosis: first clinical case of acquired azole-resistance in Colombia.
Journal: BMC infectious diseases
Published: February 06, 2026
Wild-type MIC distributions and epidemiological cut-off values for ibrexafungerp, manogepix, and rezafungin against WHO fungal priority pathogens.
Journal: International journal of antimicrobial agents
Published: January 21, 2026
The Antimicrobial Peptide C14R Is Active Against All Pathogenic Species of the ESKAPE Group.
Journal: Antibiotics (Basel, Switzerland)
Published: January 07, 2026
Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation by Candida albicans, Candidozyma auris and Candida parapsilosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025
Amyloid fibrils of the Als5p-derived peptide NH2-SNGIVIVATTRTV-COOH influence the biofilm formation of Candida albicans by shape-edging microcolony morphology.
Journal: Virulence
Published: December 10, 2025
Emerging fluconazole-resistant Candida parapsilosis in Australia: a case cluster and insights into the genetic diversity of this species.
Journal: Frontiers in microbiology
Published: November 09, 2025
In vitro evaluation of Ibrexafungerp against clinical and environmental isolates of cryptococcus neoformans and cryptococcus gattii.
Journal: Journal of global antimicrobial resistance
Published: June 18, 2025
Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity.
Journal: Journal of fungi (Basel, Switzerland)
Published: May 28, 2025
Broad Antifungal Spectrum of the Pore-Forming Peptide C14R Against Cryptococcus and Candida Species from the WHO Fungal Priority Pathogens List.
Journal: Pathogens (Basel, Switzerland)
Published: April 25, 2025
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 17, 2025
Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris.
Journal: Biomolecules
Published: January 07, 2025
Last Updated: 09/26/2026